Document is current
Any future updates will be listed below
-
Authors
Georgiades, Emily
Harrold, Caroline
Roberts, Nigel
Kassouf, Mira
Riva, Simone G.
Sanders, Edward
Downes, Damien
Francis, Helena S.
Blayney, Joseph
Oudelaar, A. Marieke
Milne, Thomas A.
Higgs, Douglas
Hughes, Jim R.
-
Funding
Funding for this research was provided by:
Medical Research Council (MC_UU_00016/14, MC_UU_00016/14, 4050189188, MC_UU_00029/3, MC_UU_00016/14, MC_UU_00016/14, MC_UU_00016/6, 4050189188, MC_UU_00016/14)
Wellcome Trust (108861/Z/15/Z, 106130/Z/14/Z, 225220/Z/22/Z, 106130/Z/14/Z, 109097/Z/15/Z, 219979/Z/19/Z, 106130/Z/14/Z, 106130/Z/14/Z, 106130/Z/14/Z)
- License Information
-
More Information
Article History
Received: 12 November 2024
Accepted: 26 March 2025
First Online: 6 April 2025
Declarations
:
: J.R.H. is founder, shareholder, and paid consultant of Nucleome Therapeutics. J.R.H hold patents for Capture-C (WO2017068379A1, EP3365464B1, US10934578B2). T.A.M. is a shareholder in and consultant for Dark Blue Therapeutics. This author declares no other financial or non-financial interests. The remaining authors declare no competing interests.
